Drug Accelerator Awards

We need to accelerate and drive forward the development of novel drugs for the treatment of Parkinson’s.

These awards will help pioneer and accelerate novel drug development for the treatment of Parkinson’s, providing researchers the opportunity to plug essential gaps in existing datasets to get their projects/compounds ready to enter full scale drug discovery with an industry partner or the Parkinson’s Virtual Biotech.

We are looking for projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson’s.

DEADLINES AND WORKSHOP 

Applicants may wish to attend a virtual workshop on Tuesday 19 July at 1 pm - 2 pm. This will be an opportunity to discuss your research ideas with members of the Parkinson's UK research and drug discovery team and to find out more about the grants scheme. Sign up for the Zoom meeting here 

The deadline for pre-proposal applications is Thursday 8 September 2022, by 4 pm.

Please email [email protected] for a copy of the pre-proposal application.

The deadline for full applications is Thursday 27 October 2022, by 4 pm for applicants who are successful at the pre proposal stage.

DURATION & VALUE

The duration of a grant is up to a maximum of 12 months. 

There is no minimum value and the maximum award amount is £100,000.

For projects involving in vivo work, a duration of 12 to 18 months and award amount up to £150,000 will be considered.

ELIGIBILITY

Grants are tenable only at a UK university, NHS Trust or small start-up biotech companies.

Principal applicants should hold employment contracts that extend beyond the period of the grant.

Co-applicants and collaborators may be based at institutions outside the UK or biotech companies. 

 

Get updates on grants

Be the first to find out about funding, events, news and opportunities in the world of research by signing up to Synapse - our enewsletter for the Parkinson's research community.